Molecular Pharming: A New Approach for a Healthy Future by a Vast Development in the Pharmaceutical Industry

Authors

  • Suhashini Marian Silva SP
  • Kithmini Siridewa

DOI:

https://doi.org/10.5530/ctbp.2021.3.32

Keywords:

Molecular pharming, biopharma-ceuticals, GMOs, transgenic animals (TAs), re-combinant proteins (RPs)

Abstract

Molecular pharming is a process in which different biopharmaceuticals are produced from genetically modified organisms (GMOs) such as microbes, transgenic animals (TAs) and transgenic plants (TPs). Out of these, transgenic plants are more advantageous as they are safer, cheaper and they do not require cold storage systems. The advent of the biotechnological arena have paved the way to transform genetic material to host organisms such as plants, thereby to produce recombinant proteins (RPs) in a large scale. It could be observed that the current techniques used to produce pharmaceuticals are not much safer and they are not affordable by developing countries. Therefore the production of RP by molecular pharming is essential. Current demand for RPs is increasing rapidly for diagnosis and pharmaceutical purposes, while scientists have developed edible vaccines and drugs for certain diseases. Currently new approaches are been carried out to develop vaccines against deadly diseases such as Dengue and Ebola using molecular pharming. Therefore molecular pharming have generated new hopes in the minds of the suffering population with these deadly diseases.

Author Biographies

Suhashini Marian Silva SP

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo.

Kithmini Siridewa

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo.Sri Lanka

Molecular Pharming: A New Approach for a Healthy Future by a Vast Development in the Pharmaceutical Industry

Downloads

Published

2021-08-18

How to Cite

SP, S. M. S., & Siridewa, K. (2021). Molecular Pharming: A New Approach for a Healthy Future by a Vast Development in the Pharmaceutical Industry. Current Trends in Biotechnology and Pharmacy, 15(3), 315–324. https://doi.org/10.5530/ctbp.2021.3.32